Britain’s junior doctors said on Tuesday they would suspend a threatened 48-hour strike planned for next week after making progress in conciliation talks with the government over pay and conditions for working anti-social hours. The junior doctors, or doctors in training who represent just over half of all doctors in the National Health Service (NHS), […]

Studies from Britain and Mexico suggest reducing sugar in sweetened drinks or taxing it more to cut consumption can help people limit their calorie intake and lower their risk of developing diabetes, but not by much.   Two separate pieces of research published on Thursday in the British Medical Journal and The Lancet Diabetes & […]

Drug companies have brought a host of expensive new medicines to market in the United States and Europe this year, figures show, another bumper haul for an industry often accused of over-charging. Drug prices are set to be a major issue in the run-up to the U.S. presidential election next year, with Democratic candidate Hillary […]

A Roche drug that can prolong the lives of some women with advanced breast cancer has been plunged back into the center of a drug pricing row after Britain’s health cost agency declared that it is still too expensive. The stand-off shows how the price of medicines is as pressing and emotive an issue in […]

British Prime Minister David Cameron is against imposing a tax on sugar as a means to tackle childhood obesity, his spokesman said on Thursday, rejecting the arguments of a high-profile campaign for a levy on sugary food and drinks.   Childhood obesity is described as one of the most serious public health challenges of the […]

Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N), under fire for price increases of its two heart drugs, said it was subpoenaed by U.S. prosecutors on its pricing, drug distribution and patient assistance programs. Valeant’s U.S.-listed shares were down 9 percent at $156.53 in premarket trading on Thursday. The company, which came under attack from Democratic lawmakers […]

U.S. prices for the world’s 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.   The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such […]

The European Union’s ban on Indian generic drugs is “unwarranted” and an obstacle to moving trade talks forward, India’s foreign secretary said on Monday.   Subrahmanyam Jaishankar said EU restrictions on more than 700 generic drugs were unfair. “It’s our hope that this matter would be looked at fairly and sensibly and would hopefully not […]

The first patient has been treated in Britain in a pioneering trial of a new treatment co-developed by Pfizer and derived from embryonic stem cells designed for patients with a condition that can cause blindness. Specialists at London’s Moorfields Eye Hospital said the operation, described as “successful”, was the first of 10 planned for participants […]

Praluent will be available in both a 75 mg and 150 mg dose for self-administration every two weeks   TARRYTOWN, N.Y. and PARIS, Sept. 28, 2015 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Commission (EC) has granted marketing authorization for Praluent® (alirocumab) for the treatment of bad cholesterol, known as […]